Polymorphism of cytochrome P450 and xenobiotic toxicity

This publication has 11 references indexed in Scilit:

• Pharmacogenetics: an opportunity for a safer and more efficient pharmacotherapy
  Journal of Internal Medicine, 2001
• Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
  Nature Genetics, 2001
• Identification and Tissue Distribution of the Novel Human Cytochrome P450 2S1 (CYP2S1)
  Biochemical and Biophysical Research Communications, 2001
• Duplications and Defects in the CYP2A6 Gene: Identification, Genotyping, and In Vivo Effects on Smoking
  Molecular Pharmacology, 2000
• The Decreased in Vivo Clearance of CYP2D6 Substrates by CYP2D6*10 Might Be Caused Not Only by the Low-Expression but Also by Low Affinity of CYP2D6
  Archives of Biochemistry and Biophysics, 2000
• Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles
  Pharmacogenetics, 2000
• Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
  Science, 1999
• Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment
  Trends in Pharmacological Sciences, 1999
• Use of In Vitro and In Vivo Data to Estimate the Likelihood of Metabolic Pharmacokinetic Interactions
  Clinical Pharmacokinetics, 1997
• Inherited amplification of an active gene in the cytochrome P450 CYP2D locus as a cause of ultrarapid metabolism of debrisoquine.
  Proceedings of the National Academy of Sciences, 1993